• Clinical Trials - Alzheimer's disease (AD)

    Study Objective Contact
    A Clock Drawing Test Scoring Application For Dementia, Vascular Disease And Parkinson's Disease: A Pilot Study [LCID Study Number: 2005-067] To collect information on the use of a digital pen in a scoring system for the Clock Drawing Test in Patients with Dementia, Vascular Disease and Healthy Controls. Principal Investigator(s):
    Dana L. Penney, PhD, ABN

    For more information about this Research Study call 781-744-8027.

    Study Coordinator(s):
    Sharmeen Alam, MHA.
    A Placebo-Controlled, Double-Blind, Parallel-Group, Bayesian Adaptive Randomization Design and Dose Regimen-Finding Study to Evaluate Safety, Tolerability and Efficacy of BAN2401 in Subjects with Early Alzheimer's Disease [LCID Study Number: 2013-011] The purpose of this study is to determine if the study drug (BAN2401) is safe and effective in subjects with Mild Cognitive Impairment due to Alzheimer’s disease or mild Alzheimer’s disease Principal Investigator(s):
    Yuval Zabar, MD

    For more information about this Research Study call 781-744-8027.

    Study Coordinator(s):
    Nick Ventura.
    Evaluating The Impact Of Cerebral Ischemic And Degenerative Changes On Cognition [LCID Study Number: 2008-029] The purpose of this research study is to evaluate whether or not cerebral atrophy scores and ischemia obtained from your brain MRI can correlate with your mini mental test results. Principal Investigator(s):
    Sami H. Erbay, MD

    For more information about this Research Study call 781-744-8027.

    Study Coordinator(s):
    Kaan D. Erbay,
    Karen L. Hanley.